<DOC>
	<DOCNO>NCT00282646</DOCNO>
	<brief_summary>Patients peripheral artery disease , stage III IV candidate interventional operative therapy treat intraarterial progenitor cell therapy ( autologous bone marrow cell ) randomize , placebo control trial .</brief_summary>
	<brief_title>Safety Feasibility Study Autologous Bone Marrow Cell Transplantation Patients With Peripheral Arterial Occlusive Disease ( PAOD )</brief_title>
	<detailed_description>Main goal : Improvement limb perfusion ( Ankle brachial index ) . Secondary aim : Reduction pain Reduction Ulcer size Walking distance Improvement tissue oxygenation ( TCO2 ) Minor major amputation</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Patients PAOD ( Stage III IV ) Distal arterial occlusion Patients Buergers Disease Signed inform consent Successful bypass operation intervention within last 3 month Active infection , feber , chronic inflammatory disease HIV , Hepatitis Tumor within last 5 year , complete remission require Stroke myocardial infarction within last 3 month Renal insufficiency ( creatinine &gt; 2 mg/dl ) Liver disease ( GOT &gt; 2x upper limit oder spontaneous INR &gt; 1,5 ) . Anemia ( hemoglobin &lt; &lt; 10 mg/dl ) Thrombocytopenia &lt; 100.000/Âµl Allergies Aspirin , Clopidogrel , Heparin Bleeding disorder Gastrointestinal bleeding within last 3 month Surgery trauma within last 2 month Pregnancy Mental retardation Inclusion clinical study within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>peripheral arterial occlusive disease</keyword>
	<keyword>[ C14.907.137 ]</keyword>
</DOC>